CG ONCOLOGY INC (CGON) Stock News

USA - NASDAQ:CGON - US1569441009 - Common Stock

43.27 USD

+0.8 (+1.88%)

Last: 10/31/2025, 8:00:01 PM

43.27 USD

0 (0%)

After Hours: 10/31/2025, 8:00:01 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CGON Latest News, Press Relases and Analysis

All

Press Releases

24 days ago - By: The Motley Fool

Why Cg Oncology Stock Rocketed 7% Higher Today

2 months ago - By: Benzinga

CG Oncology Stock Signals Bullish Momentum Ahead

3 months ago - By: The Motley Fool

Cg Oncology (CGON) Q2 Loss Widens 93%

4 months ago - By: Benzinga

Beyond The Numbers: 7 Analysts Discuss CG Oncology Stock

2 months ago - By: CG Oncology Inc.

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

2 months ago - By: CG Oncology Inc.

CG Oncology Continues to Demonstrate Best-in-Disease Durability and Tolerability in BOND-003 Cohort C; Additional 12 Patients in Complete Response at 24 Months

2 months ago - By: CG Oncology Inc.

CG Oncology Completes Enrollment in PIVOT-006

2 months ago - By: CG Oncology Inc.

CG Oncology Completes Enrollment in PIVOT-006

6 months ago - By: Zacks Investment Research - Mentions: SLAB LSTR UAA

Company News for May 14, 2025

2 months ago - By: CG Oncology Inc.

CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences

2 months ago - By: CG Oncology Inc.

CG Oncology’s Executive Leadership to Participate in Upcoming Investor Conferences

3 months ago - By: CG Oncology Inc.

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: CG Oncology Inc.

CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates

3 months ago - By: Zacks Investment Research - Mentions: ABUS

Arbutus Biopharma (ABUS) Beats Q2 Earnings and Revenue Estimates

3 months ago - By: Yahoo Finance

CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial

3 months ago - By: CG Oncology Inc.

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

3 months ago - By: CG Oncology Inc. - Mentions: ANIP

Delaware Superior Court Jury Issues Unanimous Verdict that CG Oncology Owes No Future Royalties or Other Payments to ANI Pharmaceuticals

4 months ago - By: Yahoo Finance - Mentions: LEGN MS

H.C. Wainwright Maintains a Buy on Legend Biotech (LEGN) With a $75 Price Target

4 months ago - By: Yahoo Finance - Mentions: MS OKE

Morgan Stanley Lifts PT on CG Oncology (CGON) to $56, Keeps an Overweight Rating

5 months ago - By: CG Oncology Inc.

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

5 months ago - By: CG Oncology Inc.

CG Oncology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

5 months ago - By: Zacks Investment Research - Mentions: JNJ MRK IBRX

CGON Stock Rallies 27% in a Month on Bladder Cancer Study Success

6 months ago - By: CG Oncology Inc.

CG Oncology to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

6 months ago - By: Zacks Investment Research - Mentions: ATRA

CG Oncology, Inc. (CGON) Reports Q1 Loss, Lags Revenue Estimates

6 months ago - By: CG Oncology Inc.

CG Oncology Reports First Quarter 2025 Financial Results and Provides Business Updates